Back to Ensign Peak Advisors, Inc Ensign Peak Advisors, Inc

VKTXVKTX

Showing 8 of 14 quarters

Position history for Ensign Peak Advisors, IncEnsign Peak Advisors, Inc's holdings in Viking Therapeutics, Inc.

Yes. Ensign Peak Advisors holds 7,789 shares of VKTX (Viking Therapeutics), worth $303,849, as of its Q2 2026 13F filing. It increased the position by 850 shares (+12.3%) from Q1 2026. Ensign Peak Advisors has held VKTX since Q1 2023, across 14 quarterly 13F filings.

Current Value

$303,849

Current Shares

7,789

Total Value Change

-$28.3M

Total Shares Change

-444,222

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
7,789
+12.3%
$303,8490.0%$39.01
26
2026-Q1
Unchanged
6,939
0.0%
$225,7950.0%$32.54
0
2025-Q4
Decreased
6,939
-61.0%
$244,1140.0%$35.18
0
2025-Q3
Decreased
17,789
-51.5%
$467,4950.0%$26.28
0
2025-Q2
Decreased
36,689
-78.8%
$972,2590.0%$26.50
0
2025-Q1
Decreased
172,890
-58.1%
$4.2M0.0%$24.15
0
2024-Q4
Decreased
412,656
-8.7%
$16.6M0.0%$40.24
0
2024-Q3
Unchanged
452,011
0.0%
$28.6M0.1%$63.31
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used